Treatment or mitigation of metabolic disorders with polymerized proteins combined with GLP-1 efficacy using 25 gstrico (GIPR) receptor polymerized proteins

摘要

The present Invention relates to methods for treating diseases and Metabolic Disorders using a Protein specific for the Antigen binding polypeptide gipr. In several ways, disease or Metabolic Disorder is Type 2 diabetes, obesity, dyslipidemia, elevated levels of glucose, elevated insulin levels and diabetic nephropathy.In certain types of Antigen Binding Protein is administered in combination with a glp-1 receptor agonist